These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 29527189)

  • 1. The Role of NOD Mice in Type 1 Diabetes Research: Lessons from the Past and Recommendations for the Future.
    Chen YG; Mathews CE; Driver JP
    Front Endocrinol (Lausanne); 2018; 9():51. PubMed ID: 29527189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bridging Mice to Men: Using HLA Transgenic Mice to Enhance the Future Prediction and Prevention of Autoimmune Type 1 Diabetes in Humans.
    Serreze DV; Niens M; Kulik J; DiLorenzo TP
    Methods Mol Biol; 2016; 1438():137-51. PubMed ID: 27150089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative genetics: synergizing human and NOD mouse studies for identifying genetic causation of type 1 diabetes.
    Driver JP; Chen YG; Mathews CE
    Rev Diabet Stud; 2012; 9(4):169-87. PubMed ID: 23804259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An explanation for the protective effect of the MHC class II I-E molecule in murine diabetes.
    Reich EP; Sherwin RS; Kanagawa O; Janeway CA
    Nature; 1989 Sep; 341(6240):326-8. PubMed ID: 2507922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bridging mice to men: using HLA transgenic mice to enhance the future prediction and prevention of autoimmune type 1 diabetes in humans.
    Serreze DV; Niens M; Kulik J; Dilorenzo TP
    Methods Mol Biol; 2010; 602():119-34. PubMed ID: 20012396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissimilar background genes control susceptibility to autoimmune disease in the context of different MHC haplotypes: NOD.H-2(s) congenic mice are relatively resistant to both experimental autoimmune encephalomyelitis and type I diabetes.
    Greve B; Reddy J; Waldner HP; Sobel RA; Kuchroo VK
    Eur J Immunol; 2004 Jul; 34(7):1828-38. PubMed ID: 15214031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct evidence for the contribution of the unique I-ANOD to the development of insulitis in non-obese diabetic mice.
    Miyazaki T; Uno M; Uehira M; Kikutani H; Kishimoto T; Kimoto M; Nishimoto H; Miyazaki J; Yamamura K
    Nature; 1990 Jun; 345(6277):722-4. PubMed ID: 2113614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of class III MHC to susceptibility to type 1 diabetes in the NOD mouse.
    Yamaji K; Ikegami H; Fujisawa T; Noso S; Nojima K; Babaya N; Itoi-Babaya M; Kobayashi M; Hiromine Y; Makino S; Ogihara T
    Ann N Y Acad Sci; 2006 Oct; 1079():114-7. PubMed ID: 17130540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Humanized" HLA transgenic NOD mice to identify pancreatic beta cell autoantigens of potential clinical relevance to type 1 diabetes.
    Serreze DV; Marron MP; Dilorenzo TP
    Ann N Y Acad Sci; 2007 Apr; 1103():103-11. PubMed ID: 17376821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic control of autoimmune diabetes in the NOD mouse.
    Wicker LS; Todd JA; Peterson LB
    Annu Rev Immunol; 1995; 13():179-200. PubMed ID: 7612220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of autoimmune insulitis by expression of I-E molecules in NOD mice.
    Nishimoto H; Kikutani H; Yamamura K; Kishimoto T
    Nature; 1987 Jul 30-Aug 5; 328(6129):432-4. PubMed ID: 3302721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allelic variation in class I K gene as candidate for a second component of MHC-linked susceptibility to type 1 diabetes in non-obese diabetic mice.
    Inoue K; Ikegami H; Fujisawa T; Noso S; Nojima K; Babaya N; Itoi-Babaya M; Makimo S; Ogihara T
    Diabetologia; 2004 Apr; 47(4):739-47. PubMed ID: 15298352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel NOD-derived murine model of primary Sjögren's syndrome.
    Robinson CP; Yamachika S; Bounous DI; Brayer J; Jonsson R; Holmdahl R; Peck AB; Humphreys-Beher MG
    Arthritis Rheum; 1998 Jan; 41(1):150-6. PubMed ID: 9433880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MHC-mismatched mixed chimerism mediates thymic deletion of cross-reactive autoreactive T cells and prevents insulitis in nonobese diabetic mice.
    Racine JJ; Zhang M; Wang M; Morales W; Shen C; Zeng D
    J Immunol; 2015 Jan; 194(1):407-17. PubMed ID: 25429069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of diabetogenic T cells from NOD/Lt marrow is blocked when an allo-H-2 haplotype is expressed on cells of hemopoietic origin, but not on thymic epithelium.
    Serreze DV; Leiter EH
    J Immunol; 1991 Aug; 147(4):1222-9. PubMed ID: 1869820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice.
    Nakayama M; Abiru N; Moriyama H; Babaya N; Liu E; Miao D; Yu L; Wegmann DR; Hutton JC; Elliott JF; Eisenbarth GS
    Nature; 2005 May; 435(7039):220-3. PubMed ID: 15889095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-splenocytes from non-obese diabetic mice binding to xenogeneic pancreatic beta-cells in vitro. Implication of the alpha/beta T-cell receptor and of major histocompatibility complex class II molecules from target cells.
    Martignat L; Feve B; Ouary M; Pogu S; Charbonnel B; Saï P
    J Autoimmun; 1993 Dec; 6(6):753-69. PubMed ID: 8155255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic and immunological basis of autoimmune diabetes in the NOD mouse.
    Yoshida K; Kikutani H
    Rev Immunogenet; 2000; 2(1):140-6. PubMed ID: 11324686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of insulin-dependent diabetes mellitus in non-obese diabetic mice by transgenes encoding modified I-A beta-chain or normal I-E alpha-chain.
    Lund T; O'Reilly L; Hutchings P; Kanagawa O; Simpson E; Gravely R; Chandler P; Dyson J; Picard JK; Edwards A
    Nature; 1990 Jun; 345(6277):727-9. PubMed ID: 2163026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatic NOD beta cells express MHC class II protein and the frequency of I-A(g7) mRNA-expressing beta cells strongly increases during progression to autoimmune diabetes.
    Walter U; Toepfer T; Dittmar KE; Kretschmer K; Lauber J; Weiss S; Servos G; Lechner O; Scherbaum WA; Bornstein SR; Von Boehmer H; Buer J
    Diabetologia; 2003 Aug; 46(8):1106-14. PubMed ID: 12856083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.